Alkem Laboratories Appoints Amrut Naik as New CEO Effective November 11
Alkem Laboratories has appointed Amrut Naik as its new Chief Executive Officer, effective November 11. The appointment was approved by the company's board following the nomination and remuneration committee's recommendation. Naik brings over 26 years of experience in pharmaceuticals, including branded formulations, generics, biologics, and vaccines. He holds bachelor's and master's degrees in pharmaceutical science and a PhD in pharmacology. His term will continue as long as he remains employed by the company.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 33/100.
Outlets measured: economictimes, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 3 Nov, 10:32 am. Other outlets followed.
- 1